Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Similares en SciELO
Compartir
Ginecología y obstetricia de México
versión impresa ISSN 0300-9041
Resumen
MELERO-CORTES, Lidia María; MORALES-ZARCO, Sonia; VIEITES PEREZ-QUINTELA, María Begoña y MARTINEZ-MAESTRE, María Ángeles. Plasmacytoma of uterine cervix. A case report and literature review. Ginecol. obstet. Méx. [online]. 2020, vol.88, n.8, pp.554-561. Epub 24-Sep-2021. ISSN 0300-9041. https://doi.org/10.24245/gom.v88i8.3860.
BACKGROUND:
The incidence of extramedullary plasmacytoma is low and, specifically, the gynecological location is exceptional. To date, 27 cases of gynecological plasmacytomas have been published (11 corresponding to cervical location).
CLINICAL CASE:
37-year-old patient, with no relevant medical history, who came to a consultation for abnormal uterine bleeding and bleeding. By spectroscopy, the hypertrophic and friable cervix was appreciated. Cervical biopsy verifies the diagnosis of plasmacytoma. Subsequently, an extension study ruled out involvement in other locations. Treatment consists of hysterectomy and pelvic lymphadenectomy, without adjuvant chemotherapy. The pathological and immunohistochemical studies confirmed the diagnosis. Currently, the patient is in follow-up and free of disease.
CONCLUSIONS:
Due to the scarcity of published cases of cervical plasmacytoma, there is no reference treatment. Despite this, there do not appear to be any differences between the patients treated with radiotherapy or surgery. The rate of progression to multiple myeloma varies from 14-36%. The adjuvant therapy does not change the rate of progression to multiple myeloma, so it is contraindicated.
Palabras llave : Extramedullary plasmacytoma; Multiple myeloma; Vaginal bledding; Hysterectomy; Lymphadenectomy; Immunohistochemistry; Radiotherapy.